A critical analysis of the tender points in fibromyalgia

Pain Medicine

Volumn 8, Issue 2, 2007, Pages 147-156

  Harden, R Norman ^a,f   Revivo, Gadi ^b   Song, Sharon ^c   Nampiaparampil, Devi ^d   Golden, Gary ^e   Kirincic, Marie ^a   Houle, Timothy T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b RADY CHILDREN'S HOSPITAL   (United States)

^c DEPAUL UNIVERSITY   (United States)

^d and Red Sox Foundation and Massachusetts General Hospital Home Base Program   (United States)

^e Action Physical Medicine and Rehabilitation   (United States)

^f REHABILITATION INSTITUTE OF CHICAGO   (United States)

Author keywords

Algometer; Diagnostic Criteria; Fibromyalgia; Pressure Pain Threshold; Tender Points

Indexed keywords

ADULT; ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; FEMALE; FIBROMYALGIA; HEALTH CARE ORGANIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METHODOLOGY; PAIN ASSESSMENT; PAIN THRESHOLD; QUANTITATIVE ANALYSIS; SCORING SYSTEM; TEACHING HOSPITAL; URBAN AREA;

ADULT; CLUSTER ANALYSIS; FEMALE; FIBROMYALGIA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PAIN THRESHOLD; PILOT PROJECTS; PRESSURE; PROSPECTIVE STUDIES; SEX CHARACTERISTICS;

EID: 33846968467     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2006.00203.x     Document Type: Article

References (97)

1. Sternbach RA. Pain and "hassles" in the United States: Findings of the Nuprin pain report. Pain 1986; 27: 69-80.
2. Crook J, Rideout E, Browne G. The prevalence of pain complaints in a general population. Pain 1984; 18: 299-314.
3. Andersson HI. The epidemiology of chronic pain in a Swedish rural area. Qual Life Res 1994; 3 (suppl 1): S19-26.
4. Sorensen HT, Rasmussen HH, Moller-Petersen JF, et al. Epidemiology of pain requiring strong analgesics outside hospital in a geographically defined population in Denmark. Dan Med Bull 1992; 39: 464-7.
5. Bowsher D. Prevalence of chronic pain in the British population: A telephone survey of 1,037 households. Pain Clinic 1991; 4: 223-30.
6. Croft P, Rigby AS, Boswell R, Schollum J, Silman A. The prevalence of chronic widespread pain in the general population. J Rheumatol 1993; 20: 710-3.
7. Verhaak P, Kresens J, Dekker J, Sorbi M, Bensing J. Prevalence of chronic benign pain disorder among adults: A review of the literature. Pain 1998; 77: 231-9.
8. Goldenberg LB. Fibromyalgia syndrome: An emerging but controversial condition. JAMA 1987, 257.
9. Marder W. The present and future adequacy of rheumatology manpower: A study of health care needs and physician supply. Arthritis Rheum 1991; 34: 1209-17.
10. White KP, Speechley M, Harth M, Ostbye T. Fibromyalgia in rheumatology practice: A survey of Canadian rheumatologists. J Rheumatol 1995; 22: 722-6.
11. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: Report of the multicenter criteria committee. Arthritis Rheum 1990; 33: 160-72.
12. Bengtsson A, Backman E, Lindblom B, Skogh T. Long-term follow-up of fibromyalgia patients: Clinical symptoms, muscular function, laboratory tests-An eight-year comparison study. J Musculoskelet Pain 1994; 2: 67-80.
13. Bennett RM. The contribution of muscle to the generation of fibromyalgia symptomatology. J Musculoskelet Pain 1996; 4: 35-59.
14. Campbell S, Clark S, Tindall E, Forehand M, Bennett R. Clinical characteristics of fibrositis. A "blinded" controlled study of symptoms and tender points. Arthritis Rheum 1983; 26: 817-24.
15. Clauw DJ. Fibromyalgia: More than just a musculoskeletal disease. Am Fam Physician 1995; 52: 843-51, 853-4.
16. Geel SE. The fibromyalgia syndrome: Musculoskeletal pathophysiology. Semin Arthritis Rheum 1994; 23: 347-53.
17. Petzke F, Khine A, Williams D, et al. Dolorimetry performed at 3 paired tender points highly predict overall tenderness. J Rheumatol 2001; 28: 2568-9.
18. Smythe H, Moldofsky H. Two contributions to understanding of the "fibrositis" syndrome. Bull Rheum Dis 1977; 28: 928-31.
19. Yunus M, Masi AT, Masi AT, et al. Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11: 151-71.
20. Abbadie C, Brown JL, Mantyh PW, Basbaum AI. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 1996; 70: 201-9.
21. Arroyo JF, Cohen ML. Abnormal responses to electrocutaneous stimulation in fibromyalgia. J Rheumatol 1993; 20: 1925-31.
22. Bendtsen L, Norregaard J, Jensen R, Olesen J. Evidence of qualitatively altered nociceptin in patients with fibromyalgia. Arthritis Rheum 1997; 40: 98-102.
23. Bennett DL. Neurotrophic factors: Important regulators of nociceptive function. Neuroscientist 2001; 7: 13-7.
24. Bennett RM. Emerging concepts in the neurobiology of chronic pain: Evidence of abnormal sensory processing in fibromyalgia. Mayo Clin Proc 1999; 74: 385-98.
25. Bennett RM, Clark SR, Campbell SM, Burckhardt CS. Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain. Arthritis Rheum 1992; 35: 1113-6.
26. Bradley LA, McKendree-Smith NL, Alberts KR, et al. Use of neuroimaging to understand abnormal pain sensitivity in fibromyalgia. Curr Rheumatol Rep 2000; 2: 141-8.
27. Chase R, Murphy D. Serotonin and central nervous system function. Annu Rev Pharmacol 1973; 13: 181-97.
28. Crofford LJ, Pillemer SR, Kalogeras KT, et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. Arthritis Rheum 1994; 37: 1583-92.
29. Burckhardt CS, Clark SR, Bennett RM. Fibromyalgia and quality of life: A comparative analysis. J Rheumatol 1993; 20: 475-9.
30. Drewes AM, Andreasen A, Jennum P, Nielsen KD. Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991; 20: 288-93.
31. Drewes AM, Gade K, Nielsen KD, et al. Clustering of sleep electroencephalographic patterns in patients with the fibromyalgia syndrome. Br J Rheumatol 1995; 34: 1151-6.
32. Farber L, Stratz T, Bruckle W, et al. Efficacy and tolerability of tropisetron in primary fibromyalgia-A highly selective and competitive 5-HT3 receptor antagonist. German Fibromyalgia Study Group. Scand J Rheumatol Suppl 2000; 113: 49-54.
33. Haus U, Varga B, Stratz T, Spath M, Muller W. Oral treatment of fibromyalgia with tropisetron given over 28days: Influence on functional and vegetative symptoms, psychometric parameters and pain. Scand J Rheumatol Suppl 2000; 113: 55-8.
34. Clark SR. Prescribing exercise for fibromyalgia patients. Arthritis Care Res 1994; 7: 221-5.
35. Clark SR, Jones KD, Burckhardt CS, Bennett R. Exercise for patients with fibromyalgia: Risks versus benefits. Curr Rheumatol Rep 2001; 3: 135-46.
36. Koltyn KF. Analgesia following exercise: A review. Sports Med 2000; 29: 85-98.
37. Martin L, Nutting A, MacIntosh BR, et al. An exercise program in the treatment of fibromyalgia. J Rheumatol 1996; 23: 1050-3.
38. Buckelew SP, Murray SP, Hewett JE, Johnson J, Huyser B. Self-efficacy, pain, and physical activity among fibromyalgia subjects. Arthritis Care Res 1995; 8: 43-50.
39. Burckhardt CS, Mannerkorpi K, Hedenberg L, Bjelle A. A randomized, controlled clinical trial of education and physical training for women with fibromyalgia. J Rheumatol 1994; 21: 714-20.
40. Busch A, Schachter C, Sheppard M, Peloso P, Tackulic R. Home-based videotaped program of aerobics for fibromyalgia. Arthritis Rheum 1999; 42: S220.
41. Kendall SA, Brolin-Magnusson K, Soren B, Gerdle B, Henriksson KG. A pilot study of body awareness programs in the treatment of fibromyalgia syndrome. Arthritis Care Res 2000; 13: 304-11.
42. McCain GA, Bell DA, Mai FM, Halliday PD. A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum 1988; 31: 1135-41.
43. Mengshoel AM, Komnes HB, Forre O. The effects of 20weeks of physical fitness training in female patients with fibromyalgia. Clin Exp Rheumatol 1992; 10: 345-9.
44. Nichols DS, Glenn TM. Effects of aerobic exercise on pain perception, affect, and level of disability in individuals with fibromyalgia. Phys Ther 1994; 74: 327-32.
45. Norregaard J, Lykkegaard J, Mehlsen J, Danneskiold-Samso B. Exercise training in treatment of fibromyalgia. J Musculoskelet Pain 1997; 5: 71-9.
46. Revivo G, Vo A, Song S, Golden G, Harden R. Effectiveness of Aerobic Conditioning in Improving Maximal Oxygen Uptake While Decreasing Pain in Patients with Fibromyagia: A Pilot Study. San Francisco, CA; American Academy of Physical Medicine and Rehabilitation Annual Assembly; 2000.
47. Wigers SH, Stiles TC, Vogel PA. Effects of aerobic exercise versus stress management treatment in fibromyalgia: A 4.5year prospective study. Scand J Rheumatol 1996; 25: 77-86.
48. Bannwarth B. Risk-benefit assessment of opioids in chronic noncancer pain. Drug Saf 1999; 21: 283-96.
49. Fogelholm R, Murros K. Tizanidine in chronic tension-type headache: A placebo controlled double-blind cross-over study. Headache 1992; 32: 509-13.
50. Aaron LA, Bradley LA, Alarcon GS, et al. Psychiatric diagnoses in patients with fibromyalgia are related to health care-seeking behavior rather than to illness. Arthritis Rheum 1996; 39: 436-45.
51. Buckelew SP. Biofeedback relaxation training and exercise interventions for fibromyalgia: A prospective trial. Arthritis Care Res 1998; 11: 196-209.
52. Burckhardt CS, O'Reilly CA, Wiens AN, et al. Assessing depression in fibromyalgia patients. Arthritis Care Res 1994; 7: 35-9.
53. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 1994; 37: 32-40.
54. Fassbender K, Samborsky W, Kellner M, Muller W, Lautenbacher S. Tender points, depressive and functional symptoms: Comparison between fibromyalgia and major depression. Clin Rheumatol 1997; 16: 76-9.
55. Gruber AJ, Hudson JI, Pope HG Jr. The management of treatment-resistant depression in disorders on the interface of psychiatry and medicine. Fibromyalgia, chronic fatigue syndrome, migraine, irritable bowel syndrome, atypical facial pain, and premenstrual dysphoric disorder. Psychiatr Clin North Am 1996; 19: 351-69.
56. Nielson WR, Walker C, McCain GA. Cognitive behavioral treatment of fibromyalgia syndrome: Preliminary findings. J Rheumatol 1992; 19: 98-103.
57. White KP, Nielson WR. Cognitive behavioral treatment of fibromyalgia syndrome: A follow-up assessment. J Rheumatol 1995; 22: 717-21.
58. McCarberg B, Barkin RL, Wright JA, et al. Tender points as predictors of distress and the pharmacologic management of fibromyalgiasyndrome. Am J Ther 2003; 10: 176-92.
59. McCarthy DJ Jr, Gatter RA, Phelps P. A dolorimeter for quantification of articular tenderness. Arthritis Rheum 1965; 8: 551-9.
60. Van Santen M, Bolwijn P, Landewe R, et al. High or low intensity aerobic fitness training in fibromyalgia: Does it matter? J Rheumatol 2003; 29: 582-7.
61. Fischer AA. Pressure algometry over normal muscles. Standard values, validity and reproducibility of pressure threshold. Pain 1987; 30: 115-26.
62. Hogeweg JA, Langereis MJ, Bernards AT, Faber JA, Helders PJ. Algometry. Measuring pain threshold, method and characteristics in healthy subjects. Scand J Rehabil Med 1992; 24: 99-103.
63. Jensen K, Andersen HO, Olesen J, Lindblom U. Pressure-pain threshold in human temporal region. Evaluation of a new pressure algometer. Pain 1986; 25: 313-23.
64. Vatine JJ, Shapira SC, Magora F, Adler D, Magora A. Electronic pressure algometry of deep pain in healthy volunteers. Arch Phys Med Rehabil 1993; 74: 526-30.
65. Nussbaum EL, Downes L. Reliability of clinical pressure-pain algometric measurements obtained on consecutive days. Phys Ther 1998; 78: 160-9.
66. Tunks E, Crook J, Norman G, Kalaher S. Tender points in fibromyalgia. Pain 1988; 34: 11-9.
67. Yunus MB. The role of gender in fibromyalgia syndrome. Curr Rheumatol Rep 2001; 3: 128-34.
68. Yunus MB. Gender differences in fibromyalgia and other related syndromes. J Gend Specif Med 2002; 5: 42-7.
69. Virchow R. Ueber parenchymatose entzudung. Arch Pathol Anat 1852: 4.
70. Gowers WR. Lumbago: Its lessons and analogues. BMJ 1904: 117-21.
71. Stockman R. The causes, pathology and treatment of chronic rheumatism. Edinburgh Med J 1904; 15: 352-5.
72. Kellgren JH. A preliminary account of referred pains arising from muscle. BMJ 1938; 1: 325-7.
73. Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. The Upper Extremities. Baltimore, MD: Williams & Wilkins; 1983.
74. Travell JG, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. The Lower Extremities. Baltimore, MD: Williams & Wilkins; 1992.
75. Wolfe F. Fibrositis, fibromyalgia, and musculoskeletal disease: The current status of the fibrositis syndrome. Arch Phys Med Rehabil 1988; 69: 527-31.
76. Wolfe F, Simons DG, Fricton J, et al. The fibromyalgia and myofascial pain syndromes: A preliminary study of tender points and trigger points in persons with fibromyalgia myofascial pain syndrome and no disease. J Rheumatol 1992; 19: 944-51.
77. Weinberger L. Traumatic fibromyositis: A critical enigmatic concept. West J Med 1977; 127: 99-103.
78. Wolfe F. Development of criteria for the diagnosis of fibrositis. Am J Med 1986; 81: 99.
79. Wolfe F. The design of a fibromyalgia criteria study. J Rheumatol Suppl 1989; 19: 180.
80. Wolfe F, Hawley DJ, Cathey MA, Caro X, Russel IJ. Fibrositis: Symptom frequency and criteria for diagnosis: Evaluation of 291 rheumatic disease patients and 58 normal individuals. J Rheumatol 1985; 12: 1159-63.
81. Yunus MB, Holt GS, Masi AT, Aldag JC. Fibromyalgia syndrome among the elderly. Comparison with younger patients. J Am Geriatr Soc 1988; 36: 987-95.
82. Aronoff GM. Myofascial pain syndrome and fibromyalgia: A critical assessment and alternate view. Clin J Pain 1998; 14: 74-85.
83. Bohr T. Problems with myofascial pain syndrome and fibromyalgia syndrome. Neurology 1996; 46: 593-7.
84. Cohen M, Quintner J. Fibromyalgia syndrome, a problem of tautology. Lancet 1993; 342: 906-9.
85. Rosomoff HL, Fishbain DA, Goldberg M, Santan R, Rosomoff RS. Physical findings in patients with chronic intractable benign pain of the neck and/or back. Pain 1989; 37: 279-87.
86. Tunks E, McCain GA, Hart LE, et al. The reliability of examination for tenderness in patients with myofascial pain, chronic fibromyalgia and controls. J Rheumatol 1995; 22: 944-52.
87. Fischer AA. Documentation of myofascial trigger points. Arch Phys Med Rehabil 1988; 69: 286-91.
88. Petzke F, Gracely RH, Park KM, Ambrose K, Clauw DJ. What do tender points measure? Influence of distress on 4 measures of tenderness. J Rheumatol 2003; 30: 567-74.
89. White KP, Speechley M, Harth M, Ostbye T. The London Fibromyalgia Epidemiology Study: The prevalence of fibromyalgia syndrome in London, Ontario. J Rheumatol 1999; 26: 1570-6.
90. Berglund B, Harju EL, Kosek E, Lindblom U. Quantitative and qualitative perceptual analysis of cold dysesthesia and hyperalgesia in fibromyalgia. Pain 2002; 96: 177-87.
91. Desmeules JA, Cedraschi C, Rapiti E, et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis Rheum 2003; 48: 1420-9.
92. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum 2002; 46: 1333-43.
93. Staud R. Temporal summation of pain from mechanical stimulation of muscle tissue in normal controls and subjects with fibromyalgia syndrome. Pain 2003; 102: 87-95.
94. Staud R, Vierck C, Cannon R, Mauderli A, Price D. Abnormal sensitization and temporal summation of second pain (wind-up) in patients with fibromyalgia syndrome. Pain 2001; 91: 165-75.
95. Macfarlane TV, Blinkhorn A, Worthington HV, Davies RM, Macfarlane GJ. Sex hormonal factors and chronic widespread pain: A population study among women. Rheumatology (Oxford) 2002; 41: 454-7.
96. Rollman GB, Lautenbacher S. Sex differences in musculoskeletal pain. Clin J Pain 2001; 17: 20-4.
97. Staud R, Robinson ME, Vierck CJ Jr, Price DD. Diffuse noxious inhibitory controls (DNIC) attenuate temporal summation of second pain in normal males but not in normal females or fibromyalgia patients. Pain 2003; 101: 167-74.